title: New drugs may improve, complicate treatment for multiple sclerosis.
authors.affiliation: Karolinska Institute, Stockholm, Sweden.
authors.forename: Hans
authors.initials: H
authors.lastname: Link
authors.forename: Roland
authors.initials: R
authors.lastname: Martin
mesh_terms: D017338:Cladribine / Q000009:adverse effects / Q000627:therapeutic use*; D000068876:Fingolimod Hydrochloride; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011409:Propylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D017338:Cladribine; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine